Andrew Sassine

Andrew H.
Sassine is currently Chief Financial Officer & Director at Arcturus Therapeutics, Inc. since 2019 and Chief Financial Officer & Director at Arcturus Therapeutics Ltd. since 2019.
Former roles include Chief Financial Officer & Director at Arcturus Therapeutics Holdings, Inc. from 2019 to 2025; Independent Non-Employee Director at MYnd Analytics, Inc.; Independent Director at Acorn Energy, Inc. from 2013 to 2014; Director at Meditech, Inc.; Director at Freedom Meditech, Inc.; Independent Director at FluoroPharma Medical, Inc. from 2014 to 2016; Independent Director at iCAD, Inc. from 2015 to 2025; Director at ComHear, Inc. from 2014 to 2015; Director at MD Revolution, Inc.; Independent Director at Gemphire Therapeutics, Inc. from 2015 to 2019; Independent Director at Exicure, Inc. from 2021 to 2022; Principal at Continental Bank Corp.; Portfolio Manager at Fidelity Management & Research Co. LLC from 1999 to 2011; Portfolio Manager at Fidelity Investments, Inc. from 1999 to 2012; Portfolio Manager at Heller Financial, Inc. from 1995 to 1997; Vice President-Acquisition Finance Group at Fleet National Bank from 1997 to 1999; Vice President-Acquisition Finance Group at Fleet Bank of Massachusetts, NA; Trustee at Clarke Schools for Hearing & Speech from 2009 to 2014; and Member at Henry B. Tippie College of Business.
Education includes an undergraduate degree from the University of Iowa in 1987 and an MBAistration from The Wharton School of the University of Pennsylvania in 1993.